Home
Home
Search (⌘K or ⌃K)
Data
Methodology
Data Model
About
Help
Sign In
INDEXED
Home
/
InVitroSystem
/
GM25256 (WTC-11) — IGVFSM9734OHZN
GM25256 (WTC-11) — IGVFSM9734OHZN
released
Json view
Summary
Homo sapiens (male) GM25256 (WTC-11) differentiated cell specimen induced to cardiac muscle cell for 28 days treated with 4 μM GSK3 inhibition for 7 days
Sample Terms
GM25256 (WTC-11)
Classification
differentiated cell specimen
Sex
male
Age
unknown
Targeted Sample Term
cardiac muscle cell
Time Post Change
28 day
Cell Fate Change Protocol
WTC and Cardiomyocytes Protocol.pdf
Taxa
Homo sapiens
Sources
Charles Gersbach, Duke
Aliases
charles-gersbach:in-vitro-system-bulk-rna-chir4um-ipsc-cm-rep1
Attribution
Charles Gersbach, Duke
(
HG012053
—
Charles Gersbach
)
Donors
1 item
Accession
Aliases
Sex
Taxa
IGVFDO1756PPKO
igvf:donor_of_WTC11
male
Homo sapiens
File Sets
2 items
Accession
Summary
Aliases
Lab
IGVFDS3461ZPPS
RNA-seq: fold change over control, transcript quantifications, transcriptome alignments
charles-gersbach:analysis-set-bulk-rna-DEanalysis
Charles Gersbach, Duke
IGVFDS9314PRMO
RNA-seq
charles-gersbach:measurement-set-bulk-rna-chir4um-ipsc-cm-rep1
Charles Gersbach, Duke
Treatments
1 item
Term Name
Purpose
Type
Summary
GSK3 inhibition
antagonist
chemical
Treatment of 4 μM GSK3 inhibition for 7 days
Institutional Certificates
1 item
Certificate Identifier
Data Use Limitation
Lab
IP117-03
No limitations
Charles Gersbach, Duke